Johnson & Johnson Backtracks on $2.2B Federal Deal
In 2012, Johnson & Johnson agreed to pay up to $2.2 billion to settle a federal investigation into its sales practices. But, according to The Wall Street Journal, the drug giant is now threatening to back out of the deal if forced to admit that it downplayed risks associated with its prescription drug Risperdal.
http://www.drugwatch.com/2013/06/05/federal-settlement-over-risperdal-stalls/
The FDA maintained that Janssen promoted Risperdal as safe and effective in treatment of attention deficit and hyperactivity disorder, obsessive-compulsive disorder, oppositional defiance disorder and autism despite “known health risks to children and adolescents” taking such medications. Rapid weight gain and metabolic disturbance have been seen in many young patients taking drugs in the same class as Risperdal.
The government’s complaint alleges that Janssen paid speaker’s fees to physicians in a bid to influence them to write more prescriptions for Risperdal. It also alleges that Janssen paid millions of dollars in kickbacks to Omnicare Inc., the nation’s largest pharmacy service specializing in dispensing drugs to nursing homes. The payments to Omnicare consultant pharmacists were made under the guise of market-share rebate payments, data purchasing agreements, grants and educational funding, the government alleged.
http://articles.latimes.com/2013/nov/04/science/la-sci-drugmaker-settlement-antipsychotic-20131104
You make this a thread with BILLION in the title and that will get a reaction. States should be added as keywords after posting (anyone can add a keyword).
Although I am what could be called a republican, the Lord Jesus had some mighty words for those in power and businesses get away with more crime than the poor. And don’t even get me started with the fed and the big banks. I’ve learned a ton from the liberal anti-federal reserve sites that hilariously stopped updating after an election that occurred, oh, about 6 years ago??